Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Oct. 7, 2024
The
intestinal
microbiota
is
increasingly
recognized
as
a
crucial
player
in
the
development
and
maintenance
of
various
chronic
conditions,
including
obesity
associated
metabolic
diseases.
While
most
research
focuses
on
fecal
due
to
its
easier
accessibility,
small
intestine,
major
site
for
nutrient
sensing
absorption,
warrants
further
investigation
determine
composition
functions.
Here,
we
conducted
clinical
project
30
age-
sex-matched
participants
with
(
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(6), P. 948 - 948
Published: March 8, 2025
The
Mediterranean
diet
(MD)
is
widely
recognized
for
its
health
benefits,
particularly
in
modulating
gut
microbiota
composition
and
reducing
the
risk
of
metabolic,
cardiovascular,
neurodegenerative
diseases.
Characterized
by
a
high
intake
plant-based
foods,
monounsaturated
fats,
polyphenols,
primarily
from
extra
virgin
olive
oil,
MD
fosters
growth
beneficial
bacteria
such
as
Bifidobacterium,
Faecalibacterium
prausnitzii,
Roseburia,
which
produce
short-chain
fatty
acids
that
enhance
barrier
integrity,
reduce
inflammation,
improve
metabolic
homeostasis.
Clinical
preclinical
studies
have
proved
associated
with
increased
microbial
diversity,
reduced
pro-inflammatory
bacteria,
improved
markers
insulin
sensitivity,
lipid
metabolism,
cognitive
function.
Additionally,
positively
influences
various
conditions,
including
obesity,
cardiovascular
disease,
neurodegeneration,
potentially
mitigating
systemic
inflammation
enhancing
neuroprotective
mechanisms.
Emerging
evidence
suggests
variants,
Green-MD,
their
integration
probiotics
can
further
optimize
parameters.
While
impact
on
overall
well
supported,
long-term
clinical
trials
are
needed
to
better
understand
individual
variability
dietary
interventions
tailored
different
populations.
The Journal of Physiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 13, 2025
Important
health
disparities
are
observed
in
the
prevalence
of
obesity
and
associated
non-communicable
diseases
(NCDs),
including
type
2
diabetes
(T2D)
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
among
ethnic
groups.
Yet,
underlying
factors
accounting
for
these
remain
poorly
understood.
Fructose
has
been
widely
proposed
as
a
potential
mediator
NCDs,
given
that
hepatic
fructose
catabolism
can
result
deleterious
effects,
insulin
resistance
steatosis.
Moreover,
fermentation
by
gut
microbiota
produce
metabolites
such
ethanol
acetate,
both
which
serve
substrates
de
novo
lipogenesis
(DNL)
could
therefore
contribute
to
development
conditions.
Significant
inter-ethnic
differences
composition
have
observed.
consumption
varies
across
groups,
intake
demonstrated
significantly
alter
composition,
influence
its
fermenting
properties
effects.
Therefore,
may
be
influenced
variations
consumption,
disparities.
This
review
provides
an
overview
complex
interactions
between
host
microbial
catabolism,
role
ethnicity
shaping
processes
their
impact
on
health.
Understanding
provide
insights
into
mechanisms
driving
improve
personalized
nutrition
strategies.
KEY
POINTS:
Dietary
increased
substantially
over
recent
decades,
with
rising
(NCDs)
disease.
Pronounced
different
groups
NCD
dietary
underscore
need
elucidate
Together
well-known
toxic
effects
emerging
evidence
highlights
small
intestinal
sugars
like
various
bacterial
products
There
significant
that,
combined
varying
mediate
To
comprehensively
understand
mediating
fructose-induced
adverse
future
research
should
focus
microbiota.
Future
-
account
habits
mentioned
Computational and Structural Biotechnology Journal,
Journal Year:
2025,
Volume and Issue:
27, P. 821 - 831
Published: Jan. 1, 2025
Small
Intestinal
Bacterial
Overgrowth
(SIBO)
is
linked
to
various
diseases
and
has
been
associated
with
altered
serum
amino
acid
levels.
However,
the
direct
role
of
gut
microbiome
in
these
changes
remains
unconfirmed.
This
study
employs
genome-scale
metabolic
modeling
predict
auxotrophy
peptidase
gene
profiles
small
intestinal
microbiomes
SIBO
non-SIBO
subjects.
Auxotrophy
were
further
examined
large
under
non-dysbiotic
conditions
assess
their
similarity
microbial
profile.
Our
analysis
revealed
that
abundance
auxotrophic
bacteria
higher
microbiota
intestine
than
controls.
In
patients
SIBO,
auxotrophies
decreased
compared
Peptidase
individuals
distinct
between
microbiomes,
fewer
extracellular
genes
microbiomes.
increased
Further,
there
more
significant
associations
intestine.
conclusion,
distinct.
shifts
towards
a
state
resembling
intestine,
particularly
its
genes.
highlights
potential
identifying
disruptions
which
could
inform
development
targeted
interventions.
Journal of Chemical Information and Modeling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 20, 2025
An
intriguing
feature
of
many
bacterial
membranes
is
their
prevalence
non-bilayer-forming
lipids,
such
as
the
cone-shaped
phosphatidylethanolamines
and
cardiolipins.
Many
membrane-active
antimicrobial
peptides
lower
bilayer-to-hexagonal
phase
transition
energy
barrier
in
containing
types
lipids.
Here,
we
systematically
studied
how
molecular
shape
lipids
affects
activity
peptide
EcDBS1R4,
which
known
to
be
an
efficient
fusogenic
peptide.
Using
coarse-grained
dynamics
simulations,
show
ability
EcDBS1R4
form
"hourglass-shaped"
pores,
inhibited
by
The
abundance
further
correlates
with
propensity
this
oligomerize
preferentially
antiparallel
dimers.
We
also
observe
that
promotes
segregation
anionic
When
coupled
dimerization,
charge
leads
regions
bilayer
are
devoid
rich
zwitterionic
Our
results
indicate
a
protective
role
against
pore-mediated
permeabilization
EcDBS1R4.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 12, 2025
Abstract
The
gut
microbiota
is
a
key
modulator
of
human
health
and
the
status
major
diseases
including
cancer,
diabetes
inflammatory
bowel
disease.
Central
to
survival
ability
metabolise
complex
dietary
host-derived
glycans,
intestinal
mucins.
prominent
microbe
Bacteroides
thetaiotaomicron
(B.
theta)
versatile
highly
efficient
glycan
degrader
thanks
expansion
gene
clusters
termed
polysaccharide
utilisation
loci
(PULs).
While
mechanism
action
for
several
singular
glycan-induced
PULs
have
been
elucidated,
studies
on
unusually
high
number
mucin-inducible
in
B.
theta
significantly
lag
behind.
Here
we
show
that
mucin
inducible
PUL
BT4240-50
encodes
activities
consistent
with
processing
metabolism
O
-glycoproteins
their
core
sugar
N
-acetylgalactosamine
(GalNAc).
was
also
shown
be
important
competitive
growth
mucins
vitro,
encoding
kinase
(BT4240)
critical
GalNAc
metabolism.
Additionally,
BT4240-kinase
essential
glycosaminoglycan
metabolism,
extending
function
beyond
These
data
advance
our
understanding
glycoprotein
at
mucosal
surfaces,
highlighting
as
metabolite
microbial
gut.
Current Developments in Nutrition,
Journal Year:
2025,
Volume and Issue:
9(3), P. 104564 - 104564
Published: Feb. 6, 2025
Emerging
evidence
highlights
the
importance
of
small
intestinal
microbiota
in
digestion
and
metabolism,
underscoring
challenging
need
for
human
studies
beyond
fecal
analyses.
The
TAPIR
(acronym
"healthy
fat,
happy
microbiome")
proof-of-concept
study
was
primarily
designed
to
confirm
interaction
between
dietary
lipids
healthy
adults
with
a
challenge
test.
We
also
aimed
assess
impact
plant-based
mild-ketogenic
preconditioning
diet
on
microbiome
composition
function.
Here,
we
comprehensively
describe
our
extensive
protocol
evaluate
execution.
Participants
consumed
an
8-day
diet,
followed
by
high-fat
shake
test
day
9.
During
this
test,
fasting
postprandial
aspirates
were
collected
every
20
min
via
naso-intestinal
catheter,
blood
samples
hourly.
ingested
intestine
aspiration
capsules
before
(day
0),
6
during
Dietary
compliance,
capsule
retrieval,
sample
collection,
stool
pattern,
gastrointestinal
complaints
monitored
Twenty
mean
age
48
y
(19-88
y)
body
mass
index
(BMI)
24.3
kg/m2
(19.5-30
kg/m2)
96%
compliance.
There
no
significant
changes
patterns
study.
Mean
retrieval
rate
94.7%,
weights
per
timepoint
84.2
95.4
mg
median
transit
times
32.8
49.3
h.
average
success
aspirate
collection
catheter
49%,
varying
significantly
time
points.
intervention
successful
well-tolerated.
sampled
catheters,
each
its
own
(dis)advantages.
comprehensive
description
evaluation
execution
offer
practical
insights
supporting
future
designs
food-microbe
interactions
intestine.The
trial
is
registered
at
clinicaltrials.gov
as
NCT06064266.